China Universal Asset Management Company’s Caris Life Sciences CAI Stock Holding History
Bought
Maintained
Sold
Other funds holding CAI
ZCI
SIC
PFSRSONJ
YIH
DT
KAS
China Universal Asset Management Company's CAI Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Caris Life Sciences (CAI) stake by 10% in Q2 2026, selling an estimated $90.9K and leaving 44,989 shares worth $802K. The position accounts for 0.05% of the portfolio, ranked #225.
China Universal Asset Management Company first reported a position in CAI in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.24M in Q4 2025. 44 funds tracked by Wall St. Rank hold CAI as of Q2 2026.
- China Universal Asset Management Company held 44,989 shares of Caris Life Sciences worth $802K as of Q2 2026.
- China Universal Asset Management Company sold 5,080 Caris Life Sciences shares in Q2 2026, an estimated $90.9K.
- Caris Life Sciences made up 0.05% of China Universal Asset Management Company's portfolio in Q2 2026, its #225 holding.
- China Universal Asset Management Company first reported a position in Caris Life Sciences in Q4 2025 and has held it in 3 quarters since.
- China Universal Asset Management Company's Caris Life Sciences position peaked at $1.24M in Q4 2025.
- 44 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.